This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2014 Sep 11;371(11):1039-49.

doi: 10.1056/NEJMra1404198.

Pancreatic adenocarcinoma

David P Ryan¹, Theodore S Hong, Nabeel Bardeesy

Affiliations

Affiliation

¹ From the Division of Hematology-Oncology, Department of Medicine (D.P.R., N.B.), and the Department of Radiation Oncology (T.S.H.), Massachusetts General Hospital, Boston.

PMID: 25207767
DOI: 10.1056/NEJMra1404198

Review

Pancreatic adenocarcinoma

David P Ryan et al. N Engl J Med. 2014.

. 2014 Sep 11;371(11):1039-49.

doi: 10.1056/NEJMra1404198.

Authors

David P Ryan¹, Theodore S Hong, Nabeel Bardeesy

Affiliation

¹ From the Division of Hematology-Oncology, Department of Medicine (D.P.R., N.B.), and the Department of Radiation Oncology (T.S.H.), Massachusetts General Hospital, Boston.

PMID: 25207767
DOI: 10.1056/NEJMra1404198

No abstract available

PubMed Disclaimer

Comment in

Pancreatic adenocarcinoma.
Ryan DP, Hong TS, Bardeesy N. Ryan DP, et al. N Engl J Med. 2014 Nov 27;371(22):2140-1. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427123 No abstract available.
Pancreatic adenocarcinoma.
Bükki J. Bükki J. N Engl J Med. 2014 Nov 27;371(22):2139-40. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427124 No abstract available.
Pancreatic adenocarcinoma.
Moyer MT, Gaffney RR. Moyer MT, et al. N Engl J Med. 2014 Nov 27;371(22):2140. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427125 No abstract available.

Similar articles

Optimizing methods for the diagnosis of pancreatic cancer.
Brugge WR. Brugge WR. J Clin Gastroenterol. 2007 Nov-Dec;41(10):869-70. doi: 10.1097/MCG.0b013e318146849f. J Clin Gastroenterol. 2007. PMID: 18090153 No abstract available.
Use of predictive markers in oncology: are phase 3 trials always required?
Markman M. Markman M. Oncology. 2011;81(1):1-2. doi: 10.1159/000330729. Epub 2011 Sep 2. Oncology. 2011. PMID: 21894048 No abstract available.
Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Strzelczyk J, Janiak A, Kulig A, Malecka-Panas E. Talar-Wojnarowska R, et al. J Physiol Pharmacol. 2004 Jul;55 Suppl 2:129-38. J Physiol Pharmacol. 2004. PMID: 15608367
Targets, trials, and travails in pancreas cancer.
Izeradjene K, Hingorani SR. Izeradjene K, et al. J Natl Compr Canc Netw. 2007 Nov;5(10):1042-53. doi: 10.6004/jnccn.2007.0087. J Natl Compr Canc Netw. 2007. PMID: 18053428 Review.
[Progress of targeted therapy related to K-ras mutation].
Li ZW, Liu YQ. Li ZW, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):59-61. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22455857 Review. Chinese. No abstract available.

See all similar articles

Cited by

CAFs/tumor cells co-targeting DNA vaccine in combination with low-dose gemcitabine for the treatment of Panc02 murine pancreatic cancer.
Geng F, Dong L, Bao X, Guo Q, Guo J, Zhou Y, Yu B, Wu H, Wu J, Zhang H, Yu X, Kong W. Geng F, et al. Mol Ther Oncolytics. 2022 Jul 31;26:304-313. doi: 10.1016/j.omto.2022.07.008. eCollection 2022 Sep 15. Mol Ther Oncolytics. 2022. PMID: 36090474 Free PMC article.
Self-Expandable Metallic Stent Placement in Malignant Gastric Outlet Obstruction: A Comparison Between 2 Brands of Stents.
Ye BW, Lee KC, Hsieh YC, Li CP, Chao Y, Hou MC, Lin HC. Ye BW, et al. Medicine (Baltimore). 2015 Jul;94(29):e1208. doi: 10.1097/MD.0000000000001208. Medicine (Baltimore). 2015. PMID: 26200641 Free PMC article.
Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer.
Kang H, Kim SS, Sung MJ, Jo JH, Lee HS, Chung MJ, Park JY, Park SW, Song SY, Park MS, Bang S. Kang H, et al. Cancers (Basel). 2022 Sep 26;14(19):4672. doi: 10.3390/cancers14194672. Cancers (Basel). 2022. PMID: 36230595 Free PMC article.
Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.
Guillaumond F, Bidaut G, Ouaissi M, Servais S, Gouirand V, Olivares O, Lac S, Borge L, Roques J, Gayet O, Pinault M, Guimaraes C, Nigri J, Loncle C, Lavaut MN, Garcia S, Tailleux A, Staels B, Calvo E, Tomasini R, Iovanna JL, Vasseur S. Guillaumond F, et al. Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2473-8. doi: 10.1073/pnas.1421601112. Epub 2015 Feb 9. Proc Natl Acad Sci U S A. 2015. PMID: 25675507 Free PMC article.
Advances in targeted therapies for hepatocellular carcinoma in the genomic era.
Llovet JM, Villanueva A, Lachenmayer A, Finn RS. Llovet JM, et al. Nat Rev Clin Oncol. 2015 Jul;12(7):408-24. doi: 10.1038/nrclinonc.2015.103. Epub 2015 Jun 9. Nat Rev Clin Oncol. 2015. PMID: 26054909 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal